297 related articles for article (PubMed ID: 25688509)
21. PER2 integrates circadian disruption and pituitary tumorigenesis.
Guo L; Cen H; Weng J; He Y; Guo X; He D; Liu K; Duan S; Yang J; Zhang X; Qin Z; Wan Y; Chen Z; Wu B
Theranostics; 2023; 13(8):2657-2672. PubMed ID: 37215573
[No Abstract] [Full Text] [Related]
22. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
23. Clock genes and cancer.
Wood PA; Yang X; Hrushesky WJ
Integr Cancer Ther; 2009 Dec; 8(4):303-8. PubMed ID: 20042409
[TBL] [Abstract][Full Text] [Related]
24. c-myc oncogene expression and cell proliferation in mixed oligo-astrocytoma.
Banerjee M; Dinda AK; Sinha S; Sarkar C; Mathur M
Int J Cancer; 1996 Mar; 65(6):730-3. PubMed ID: 8631582
[TBL] [Abstract][Full Text] [Related]
25. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
26. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
Horbinski C; Wang G; Wiley CA
Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor gene expression in high grade gliomas.
Larysz D; Kula D; Kowal M; Rudnik A; Jarząb M; Blamek S; Bierzyńska-Macyszyn G; Kowalska M; Bażowski P; Jarząb B
Folia Neuropathol; 2011; 49(1):28-38. PubMed ID: 21455841
[TBL] [Abstract][Full Text] [Related]
28. Expression of Circadian Clock Genes in Human Colorectal Cancer Tissues Using Droplet Digital PCR.
Orhan T; Nielsen PB; Hviid TVF; Rosen AW; Gögenür I
Cancer Invest; 2019; 37(2):90-98. PubMed ID: 30732490
[TBL] [Abstract][Full Text] [Related]
29. [Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin].
Molnár P; Méhes G
Magy Onkol; 2009 Mar; 53(1):33-8. PubMed ID: 19318324
[TBL] [Abstract][Full Text] [Related]
30. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.
Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M
Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693
[TBL] [Abstract][Full Text] [Related]
31. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
32. SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.
Lindemann C; Hackmann O; Delic S; Schmidt N; Reifenberger G; Riemenschneider MJ
Acta Neuropathol; 2011 Aug; 122(2):241-51. PubMed ID: 21590492
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
[TBL] [Abstract][Full Text] [Related]
34. Alterations of circadian clockworks during differentiation and apoptosis of rat ovarian cells.
Chu G; Yoshida K; Narahara S; Uchikawa M; Kawamura M; Yamauchi N; Xi Y; Shigeyoshi Y; Hashimoto S; Hattori MA
Chronobiol Int; 2011 Jul; 28(6):477-87. PubMed ID: 21797776
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation of the BMAL1 promoter.
Satou R; Sugihara N; Ishizuka Y; Matsukubo T; Onishi Y
Biochem Biophys Res Commun; 2013 Oct; 440(3):449-53. PubMed ID: 24103761
[TBL] [Abstract][Full Text] [Related]
36. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
Costello JF; Berger MS; Huang HS; Cavenee WK
Cancer Res; 1996 May; 56(10):2405-10. PubMed ID: 8625319
[TBL] [Abstract][Full Text] [Related]
37. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
38. [Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance].
Tan PG; Li ZQ; Cai WQ; Lu JP; Xie FS; Weng Y
Ai Zheng; 2003 Oct; 22(10):1077-80. PubMed ID: 14558955
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
